Melanoma Clinical Trials in Beijing, Beijing Municipality
8 recruitingBeijing, Beijing Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Phase 1Phase 2
OH2 Injection in Combination With HX008 for Melanoma.
Melanoma
Binhui Biopharmaceutical Co., Ltd.60 enrolled1 locationNCT04616443
Recruiting
Phase 1Phase 2
OH2 Injection in Solid Tumors
MelanomaSolid Tumor
Binhui Biopharmaceutical Co., Ltd.30 enrolled1 locationNCT04386967
Recruiting
Phase 3
OH2 Injection in Melanoma
Melanoma
Binhui Biopharmaceutical Co., Ltd.340 enrolled30 locationsNCT05868707
Recruiting
Phase 2
A Study of IBI363 in Subjects With Advanced Melanoma
Melanoma
Innovent Biologics (Suzhou) Co. Ltd.150 enrolled12 locationsNCT06081920
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
Melanoma
Innovent Biologics (Suzhou) Co. Ltd.180 enrolled31 locationsNCT06797297
Recruiting
Phase 2
Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
MelanomaAcral MelanomaNeoadjuvant+4 more
Peking University Cancer Hospital & Institute60 enrolled1 locationNCT05512481
Recruiting
Phase 3
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Melanoma
Shanghai Kechow Pharma, Inc.165 enrolled1 locationNCT06008106